AMD vs PFE: Which Is the Better Buy?
Side-by-side comparison of Advanced Micro Devices, Inc. and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-06.
Advanced Micro Devices, Inc. · Technology
$555.79
+24.0% upside to fair value
Grade B
VS
Pfizer Inc. · Healthcare
$25.22
+2.8% upside to fair value
Grade B
QuantHub Verdict
AMD has more upside to fair value
(+24.0%).
PFE trades at a lower forward P/E
(19.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
AMD |
PFE |
| Current Price |
$555.79 |
$25.22 |
| Fair Value Estimate |
$689.29 |
$25.92 |
| Upside to Fair Value |
+24.0%
|
+2.8%
|
| Market Cap |
$906.3B |
$143.7B |
| Forward P/E |
177.7x
|
19.2x
|
| EV / EBITDA |
110.2x
|
12.3x
|
| Price / Sales |
24.1x
|
2.3x
|
| Price / FCF |
105.3x
|
15.2x
|
| Revenue Growth YoY |
+37.8%
|
+5.4%
|
| Gross Margin |
50.3%
|
69.3%
|
| Operating Margin |
11.7%
|
23.4%
|
| Return on Equity |
8.1%
|
8.4%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
0.95%
|
6.6%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Advanced Micro Devices, Inc. (AMD) is a leading semiconductor company specializing in high-performance CPUs and GPUs with a competitive moat driven by technical innovation and ecosystem scale. Under CEO Dr. Lisa Su's leadership since 2014, AMD has transformed from a $2 billion market cap to over $90 billion, gaining significant market share from Intel and Nvidia. The company reported $34.6 billio…
Pfizer Inc. is a leading global biopharmaceutical company with a diversified portfolio dominated by its Biopharma prescription segment, which accounts for over 90% of revenue. The company benefits from a substantial scale, a broad product portfolio including top-selling drugs like Eliquis, Prevnar, and Paxlovid, and a strong manufacturing footprint. However, Pfizer faces challenges from declining…
Accumulation Zones
| Metric |
AMD |
PFE |
| Zone Low |
$516.97 |
$19.44 |
| Zone High |
$585.90 |
$22.03 |
| In Buy Zone? |
Yes
|
No
|